As expected, the IGH::DUX4‐driven transcriptomic signatures were consistently observed in the NALM‐6 cells, NALM‐6TCF12−/− + TCF12 cells, and B‐ALL patients (Figure S9). Here, DUX4 is linked to acute lymphoblastic leukemia.